A wearable training apparatus has a vision-control assembly and a head-mounting assembly coupled to the vision-control assembly. The vision-control assembly has a see-through area corresponding to a central portion of the human field of vision (FOV), and a vision-blocking area for blocking the human peripheral FOV except the central portion thereof. The wearable training apparatus may be in the form of a pair of eyeglasses with lenses provided with reduced FOV or alternatively, may be in the form of a goggle with reduced FOV. A training system may comprise one or more wearable training apparatus, one or more imaging devices for recording images and/or video streams of the performance of users wearing the training apparatuses, and one or more computing devices for playing back and analyzing the recorded images and/or video streams.

A wearable training apparatus has a vision-control assembly and a head-mounting assembly coupled to the vision-control assembly. The vision-control assembly has a see-through area corresponding to a central portion of the human field of vision (FOV), and a vision-blocking area for blocking the human peripheral FOV except the central portion thereof. The wearable training apparatus may be in the form of a pair of eyeglasses with lenses provided with reduced FOV or alternatively, may be in the form of a goggle with reduced FOV. A training system may comprise one or more wearable training apparatus, one or more imaging devices for recording images and/or video streams of the performance of users wearing the training apparatuses, and one or more computing devices for playing back and analyzing the recorded images and/or video streams.

Eyeglasses are disclosed that include eyeglass frames and a pair of ophthalmic lenses mounted in the frames. The lenses include a dot pattern distributed across each lens, the dot pattern including an array of dots spaced apart by a distance of 1 mm or less, each dot having a maximum dimension of 0.3 mm or less, the dot pattern including a clear aperture free of dots having a maximum dimension of more than 1 mm, the clear aperture being aligned with a viewing axis of a wearer of the pair of eyeglasses.

Eyeglasses are disclosed that include eyeglass frames and a pair of ophthalmic lenses mounted in the frames. The lenses include a dot pattern distributed across each lens, the dot pattern including an array of dots spaced apart by a distance of 1 mm or less, each dot having a maximum dimension of 0.3 mm or less, the dot pattern including a clear aperture free of dots having a maximum dimension of more than 1 mm, the clear aperture being aligned with a viewing axis of a wearer of the pair of eyeglasses.

A contact lens (200) having an optical axis (240) and comprising an aperture (220) on the surface (210) is disclosed. The aperture (220) is located off-center of the optical axis (240) and the aperture (220) has a central axis which is arranged such that collimated light existing the aperture (220) is directed towards a blind spot (135) at the head of an optic nerve.

A contact lens (200) having an optical axis (240) and comprising an aperture (220) on the surface (210) is disclosed. The aperture (220) is located off-center of the optical axis (240) and the aperture (220) has a central axis which is arranged such that collimated light existing the aperture (220) is directed towards a blind spot (135) at the head of an optic nerve.

A side shield for use with an eyeglass frame includes an attachment body having an upper portion and a lower portion. The attachment body is sized and configured to be insertable within a respective inner periphery of the eyeglass frame. An upper projection extends from the upper portion of the attachment body and is configured to be engageable with a respective lens frame body. A lower projection extends from the lower portion of the attachment body and is configured to be engageable with the respective lens frame body. A side shielding wall is connected to the attachment body and includes an upper edge at least partially defining a void sized to allow for pivotal movement of a respective one of the pair of temple arms when the upper and lower projections are engaged with the respective lens frame body.

A side shield for use with an eyeglass frame includes an attachment body having an upper portion and a lower portion. The attachment body is sized and configured to be insertable within a respective inner periphery of the eyeglass frame. An upper projection extends from the upper portion of the attachment body and is configured to be engageable with a respective lens frame body. A lower projection extends from the lower portion of the attachment body and is configured to be engageable with the respective lens frame body. A side shielding wall is connected to the attachment body and includes an upper edge at least partially defining a void sized to allow for pivotal movement of a respective one of the pair of temple arms when the upper and lower projections are engaged with the respective lens frame body.

Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.

Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.